Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 12,799	$ 13,760
Short-term investments	63,620	52,243
Research and development tax credits receivable	837	643
Prepaid expenses	2,523	3,178
Other receivables	1,211	3,208
Total current assets	80,990	73,032
Operating lease right-of-use assets	1,515	1,917
Property and equipment	201	277
Total assets	82,706	75,226
Current liabilities
Accounts payable and accrued liabilities	4,676	6,680
Operating lease liabilities	582	546
Total current liabilities	5,258	7,226
Operating lease liabilities, net of current portion	1,002	1,457
Senior secured convertible notes	52,434	49,772
Total liabilities	58,694	58,455
Shareholders' Equity
Common shares, no par value, unlimited shares authorized 53,269,565 shares issued and outstanding as of June 30, 2024, 33,483,111 shares issued and outstanding as of December 31, 2023	288,006	260,504
Pre-funded warrants - 12,910,590 issued and outstanding as of June 30, 2024 and 9,577,257 as of December 31, 2023	53,076	48,459
Additional paid-in capital	38,112	33,834
Accumulated deficit	(355,182)	(326,026)
Total shareholders' equity	24,012	16,771
Total liabilities and shareholders' equity	$ 82,706	$ 75,226